• 1
    Sedgh G, Jussain R, Bankole A, Singh S. Women with an unmet need for contraception in developing countries and their reasons for not using a method. Occasional Report No. 37. New York: Guttmacher Institute; 2007.
  • 2
    Chiou CF, Trussell J, Reyes E, Knight K, Wallace J, Udani J, et al. Economic analysis of contraceptives for women. Contraception 2003;68:310.
  • 3
    World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use, 4th edn. Geneva: World Health Organization, 2010.
  • 4
    Rochat TJ, Richter LM, Doll HA, Buthelezi NP, Tomkins A, Stein A. Depression among pregnant rural South African women undergoing HIV testing. JAMA 2006;295:13768.
  • 5
    Reynolds HW, Janowitz B, Wilcher R, Cates W. Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. Sex Transm Infect 2008;84(Suppl 2):4953.
  • 6
    Faculty of Family Planning Clinical Health Care Effectiveness Unit. The copper intrauterine device as long term contraception. J Fam Plann Reprod Health Care 2004;30:2942.
  • 7
    Faculty of Family Planning Clinical Health Care Effectiveness Unit. The levonorgestrel-releasing intrauterine system in reproductive health contraception. J Fam Plann Reprod Health Care 2004;30:99109.
  • 8
    Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010; Adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edn. MMWR Early Release 2010;59:May 28.
  • 9
    Berwick DM. Disseminating innovations in health care. JAMA 2003;289:196975.
  • 10
    Harper C, Holt K, Nhemachena T, Chipato T, Ramjee G, Stratton L, et al. Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa. AIDS Behav 2012;7:18219.
  • 11
    Sheldon WR, Nhemachena T, Blanchard K, Chipato T, Ramjee G, Trussell J, et al. Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis 2012;39:56775.
  • 12
    Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA 2000;283:171522.
  • 13
    Harper CC, Blum M, de Bocanegra HT, Darney PD, Speidel JJ, Policar M, et al. Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet Gynecol 2008;111:135969.
  • 14
    Harper CC, Henderson JT, Raine TR, Goodman S, Darney PD, Thompson KM, et al. Evidence-based IUD practice: family physicians and obstetrician–gynecologists. Fam Med 2012;44:56472.
  • 15
    Curtis KM, Nanda K, Kapp N. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS 2009;23(Suppl 1):S5567.
  • 16
    Stanwood NL, Garrett JM, Konrad TR. Obstetrician–gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 2002;99:27580.
  • 17
    Postlethwaite D, Shaber R, Mancuso V, Flores J, Armstrong M. Intrauterine contraception: evaluation of clinician practice patterns in Kaiser Permanente Northern California. Contraception 2007;75:17784.
  • 18
    Osei I, Birungi H, Addico G, Askew I, Gyapong JO. What happened to the IUD in Ghana? Afr J Reprod Health 2005;9:7691.
  • 19
    Aziz FA, Osman AA. Safety of intrauterine device insertion by trained nurse-midwives in the Sudan. Adv Contracept 1999;15:914.